EAACI Congress 2024

Back
31 May - 03 June 2024 Valencia, Spain

D1.256 - Safety of Remibrutinib in Patients With Chronic Spontaneous Urticaria: Results From the Phase 3 REMIX-1 and REMIX-2 Studies

Friday 31 May, 12:00 PM - 12:00 PM Valencia, Spain